Track topics on Twitter Track topics that are important to you
electroCore (Nasdaq:ECOR) today announced the closing of its initial public offering of 5,200,000 shares of common stock at a public offering price of $15.00 per share. The proceeds from this offering...
An initial public offering of 5.2 million shares is expected to be priced by electroCore at $15 each in hopes of raising $78 -More-
ElectroCore's gammaCore noninvasive vagus nerve stimulation therapy has been granted expanded 510(k) clearance for adjunctive -More-
An initial public offering of 4.3 million shares has been priced by electroCore between $14 and $16 each in hopes of raising -More-
electroCore (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an expanded label ...
Noninvasive vagus nerve stimulation (nVNS) device company electroCore LLC (focused on neurology and rheumatology) filed for its initial public offering.
(Reuters) - U.S. medical device maker electroCore Llc's initial public offering is expected to price at $15 per share, Chief Executive Officer Frank Amato told Reuters on Thursday.
Noninvasive vagus nerve stimulation (nVNS) device company electroCore Inc. (focused on neurology and rheumatology) netted $72.5mm in its initial public offering of 5.2mm shares at $15, the midpoint of...
To evaluate the efficacy, safety, and tolerability of noninvasive vagus nerve stimulation (nVNS; gammaCore; electroCore, LLC, Basking Ridge, NJ) for the acute treatment of migraine in a multicenter, d...
Primary Sjögren's syndrome (pSS) sufferers have rated chronic fatigue as the most important symptom needing improvement. Emerging data suggest that stimulation of the vagus nerve can modulate immunol...
The tasks of the project are to map the potency and kinetics of the neurologic, autonomic peripheral, inflammatory, and behavioral responses to vagal nerve stimulation (VNS) vs. sham treat...
electroCore LLC, the New Jersey based bioelectric pharma company, is focused on developing non-invasive vagus nerve stimulation therapies (the gammaCore device) for the treatment ...
electroCore LLC, the New Jersey based bioelectric pharma company, is focused on developing non-invasive vagus nerve stimulation therapies for the treatment of multiple conditions ...
We have published hundreds of electroCore news stories on BioPortfolio along with dozens of electroCore Clinical Trials and PubMed Articles about electroCore for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of electroCore Companies in our database. You can also find out about relevant electroCore Drugs and Medications on this site too.